Hormone replacement therapy: Prevalence, compliance and the 'healthy women' notion

Climacteric

Volumn 1, Issue 1, 1998, Pages 42-49

  MacLennan, A H ^a,c   Wilson, D H ^b   Taylor, A W ^b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b South Australian Health Commission   (Australia)

^c WOMEN S AND CHILDREN S HOSPITAL   (Australia)

Author keywords

Breast cancer; Compliance; Estrogen; Hormone replacement therapy; Prevalence

Indexed keywords

AGE; AGED; ARTICLE; AUSTRALIA; EDUCATIONAL STATUS; ESTROGEN THERAPY; FEMALE; HEALTH STATUS; HEALTH SURVEY; HUMAN; HYSTERECTOMY; INCOME; MAMMOGRAPHY; MIDDLE AGED; OSTEOPOROSIS; PATIENT COMPLIANCE; STATISTICS; WOMEN'S HEALTH;

AGE FACTORS; AGED; AUSTRALIA; EDUCATIONAL STATUS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HEALTH STATUS; HEALTH SURVEYS; HUMANS; HYSTERECTOMY; INCOME; MAMMOGRAPHY; MIDDLE AGED; OSTEOPOROSIS; PATIENT COMPLIANCE; WOMEN'S HEALTH;

EID: 0032029034     PISSN: 13697137     EISSN: None     Source Type: Journal    
DOI: 10.3109/13697139809080680     Document Type: Article

References (32)

1. McKinlay JB, McKinlay SM, Brambilla DJ. Health status and utilization behavior associated with the menopause. Am J Epidemiol 1987;125: 110-21
2. Hahn RG, Nachtibal RD, Davies TC. Compliance difficulties with progestin supplemented replacement therapy. J Fam Pract 1984;18:411-14
3. Ryan PJ, Harrison R, Blake GM, Fogelman J. Compliance with hormone replacement therapy (HRT) after screening for postmenopausal osteoporosis. Br J Obstet Gynaecol 1992;99: 325-8
4. Kaufert PL. The menopausal transition: the use of estrogen. Can J Public Health 1986;77 (Suppl 1):86-91
5. Hemminki E, Brambilla DJ, McKinlay SM, Posner JP. Use of estrogens among middle-aged Massachusetts women. Drug Intell Clin Pharm 1991;25:418-23
6. Jolleys JV, Olesen F. A comparative study of prescribing of hormone replacement therapy in USA and Europe. Maturitas 1996;23:47-53
7. Carr BR. HRT management: the American experience. Eur J Obstet Gynaecol Reprod Biol 1996; 64:517-20
8. Johannes CB, Crawford SL, Posner JG, McMahon SM. Longitudinal patterns and correlates of hormone replacement therapy use in middle-aged women. Am J Epidemiol 1994;140:439-52
9. MacLennan A, Wilson D, Taylor A. Changes in the use of hormone replacement therapy in South Australia. Med J Aust 1995;162:420-2
10. Jacobs HS. Not for everybody. Br Med J 1996; 313:351-2
11. Toozs-Hobson P, Cardozo L. Hormone replacement therapy for all? Universal prescription is desirable. Br Med J 1996;313:350-1
12. Prentice RL, Rossouw JE, Johnson SR, Freeman LS, McTiernan A. The role of randomized controlled trials in assessing the benefits and risks of long term hormone replacement therapy: examples of the Women's Health Initiative. J Am Med Assoc 1996;3:71-6
13. Barrett-Connor E. Postmenopausal estrogen and prevention bias. Ann Intern Med 1991;115: 455-6
14. Handa VL, Landerman R, Hanlon JT, Harris T, Cohen HJ. Do older women use estrogen replacement? Data from the Duke Established Populations for Epidemiologic Studies of the Elderly (EPESE). J Am Geriatr Soc 1996;44:1-6
15. Cauley J, Cummings SR, Black DM, Mascioli SR, Seeley DG. Prevalence and determinants of estrogen replacement therapy in older women. Am J Obstet Gynecol 1990;5:1438-44
16. Norman SG, Studd JW. A survey of views on hormone replacement therapy. Br J Obstet Gynaecol 1994;101:879-87
17. Dennerstein L, Shelley J, Smith AM, Ryan M. Hysterectomy experience among mid-aged Australian women. Med J Aust 1994;161:311-13
18. Wilson DH, Wakefield M, Taylor AW. The South Australian Health Omnibus Survey. Health Promotion J Aust 1992;2:47-9
19. MacLennan AH, Wilson DH, Taylor AW. The prevalence and cost of alternative medicine in Australia. Lancet 1996;347:569-73
20. Wakefield M, Taylor A, Wilson D, Roberts L. Differences in self reported health status between ever-smokers and never-smokers. Tobacco Control 1995;4:399-401
21. Wilson D, Taylor A, Roberts L. Can we target smoking groups more effectively? A study of male and female heavy smokers. Prev Med 1995;24: 363-8
22. Australian Bureau of Statistics. Estimated Resident Population by Sex and Age: States and Territories of Australia, June 1991. Catalogue no. 3201.1. Canberra: ABS, 1992
23. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: John Wiley, 1989
24. Rozenberg S, Vandromme J, Kroll M, Twagirayezu P, Vyankandondera J. Compliance with hormone replacement therapy. Rev Med Brux 1995;16:295-8
25. Moorhead T, Hannaford P, Warskyj M. Prevalence and characteristics associated with use of hormone replacement therapy in Britain. Br J Obstet Gynaecol 1997;104:290-7
26. Ravnikar VA. Compliance with hormone replacement therapy: are women receiving the full impact of hormone replacement therapy preventive health benefits? Wom Health Issues 1992;2:75-82
27. Hammond CB. Women's concerns with hormone replacement therapy - compliance issues. Fertil Steril 1994;62:1578-608
28. Hilditch JR, Lewis J, Ross AH, et al. A comparison of the effects of oral conjugated equine estrogen and transdermal estradiol-17β combined with an oral progestin on quality of life in post-menopausal women. Maturitas 1996;24:177-84
29. MacLennan AH, MacLennan A, Wilson D. The prevalence of oestrogen replacement therapy in South Australia. Maturitas 1993;16:175-83
30. Willis DB, Callee EE, Miracle-McMahill HL, Heath CW. Estrogen replacement therapy and risk of fatal breast cancer in a prospective cohort of post-menopausal women in the United States. Cancer Causes Control 1996;7:449-57
31. Brazier JE, Harper R, Jones NMB, et al. Validating the SF-36 health survey questionnaire: a new outcome measure for primary care. Br Med J 1992;305: 160-4
32. McCallum J. The New 'SF-36' Health Status Measure: Australian Validity Tests. Canberra: National Centre for Epidemiology and Population Health, 1994